Recent Events
No events found.
Press releases
The second round has started: The Voluntary Scientific Year programme has been successful
The new group is here! On 3 September 2012, 60 young adults from the Hannover Medical School (MHH), the Leibniz University of Hannover as well as cooperating institutes began their Voluntary Scientific Year (FWJ). It was just... [more]
The overestimated noble metal: Silver is not the well-tolerated bacterial killer, it seemed to be
For a long time now silver is used in medicine, due to its antibacterial effect. Professor Dr Stephan Barcikowski’s team of the Center for Nanointegration (CENIDE) at the Universität Duisburg-Essen (UDE) has now discovered that... [more]
MHH and Rentschler Sign Licensing Agreement for an Innovative Gene Therapy Vector System
The Hannover Medical School (MHH) and Rentschler Biotechnologie GmbH have signed a licensing agreement for the commercialization of a vector system for gene therapy that promises significant therapeutic and economic advantages... [more]
REBIRTH successful in the second phase of the Excellence Initiative
Success for Hannover Medical School (MHH): within the Excellence Initiative jointly funded by Germany’s federal and state governments, MHH is to receive funding for its two Clusters of Excellence entitled ‘From Regenerative... [more]
New to the REBIRTH team
Dr. Sotiris Korossis has recently started working as Director of Biomedical Engineering at the Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (HTTG) at Hannover Medical School (MHH). Dr Korossis completed... [more]
Ten years of innovative heart valves from Hannover
Bright eyes and happy smiles on the faces of children, young people and adults alike are nothing unusual at Hannover Adventure Zoo. On Saturday, however, it was a very special group that met at the zoo to have fun together:... [more]
Abitur and then what? The Voluntary Scientific Year
This year the Hannover Medical School (MHH) offers the Voluntary Scientific Year (FWJ) again. The FWJ is a pilot scheme under the auspices of Germany’s ‘Freiwilliges Soziales Jahr‘ or FSJ – enabling upper secondary-school leavers... [more]
„Medical history being made in Hannover“
The medicine of tomorrow is already reality today: on a visit to Hannover Medical School (MHH), Federal Minister Dr Ursula von der Leyen, the patron of the association promoting children’s heart centres in Germany... [more]
REBIRTH researchers untangel blood vessel branching
New perspectives for vessel regeneration: Blood vessels form intricate, three-dimensional branched structures that supply each organ with oxygen and nutrients. However, once adult blood vessels are established they do not easily... [more]
Zender receives Johann Georg Zimmermann Award
One of the most prestigious awards for contributions to cancer research in Germany is to be presented by Deutsche Hypothekenbank AG at Hannover Medical School (MHH) on Monday, 16 January 2012. The Johann Georg Zimmermann Research... [more]
Transplantation: study on heart valves that last a lifetime
Transplanting a heart valve that is not rejected, lasts a lifetime and, in children, even grows with the body – this is the aim of the ‘European clinical study for the application of regenerative heart valves’ (ESPOIR). Headed by... [more]
The first high-tech auction in Germany: 25 investors buy a stake in REBIRTH Spin-off
The Hannover-based nanotechnology company called Particular, a spin-off from REBIRTH’s Nanoparticles work group, is the first German high-tech start-up to successfully hold a crowdfunding auction: it raised 100,000 euros’ worth... [more]
TV report: Will artificial and pig heart valves soon be a thing of the past?
Professor Haverich gives TV interview for the medical magazine programme ‘Visite’ On 22 November 2011 at 8.15 p.m. in its feature item entitled ‘New heart valves: which method for which patient?’ the NDR network’s health show... [more]
Klusmann leads Emmy Noether junior research group
To better understand the origins of leukaemia and thus develop therapies for this disease, the work group led by Dr Jan-Henning Klusmann is investigating the role played by ribonucleic acids in blood formation. Dr Klusmann, a... [more]
REBIRTH spin-off sells shares in nanotechnology profits
The Hannover-based company called Particular GmbH, a spin-off from REBIRTH’s Nanoparticles research group which produces nanoparticles for biological and medical uses, sees itself not only as a technological trailblazer for... [more]